跳到正文

疾病

胃癌Stomach cancer

胃癌 · ICD-10:C16 — Malignant neoplasm of stomach

疾病详情

规范中文名
胃癌
英文名
Malignant neoplasm of stomach

以中文写出的数值按来源原样引用。

又称

  • 胃恶性肿瘤
  • 胃腺癌
  • Gastric cancer
  • GC

治疗费用区间

以下每个区间都按一种计费口径发布:医保报销前。 来源未发布报销后数值,因此这里不展示。

治疗路径 费用区间 价格依据 数据年份
手术 54000 – 80040 CNY 病种打包全包价 2020–2025
放疗 42000 – 50000 CNY 项目价 2025–2026
化疗 6550 – 9500 CNY 病种打包全包价 2020–2021
靶向 84000 – 105000 CNY 项目价 2024–2025
免疫 36720 – 145080 CNY 项目价 2024–2025

上方的条形共用同一刻度:每条从该行已发布的下限值起,到其上限值止。本页最高的上限值为 145080 CNY。每行保留自己的数据年份与口径。

该疾病的 5 个费用区间,来源见各行页面。

以中文写出的数值按来源原样引用。

查看全部费用区间 →

五年生存

5 年生存率 35.2% 95% 置信区间 35.0–35.4

人群
总体(全分期合并)· 年龄标准化相对生存率
时期
2019–2021
发布机构
国家癌症中心
数值性质
估计值(混合法)
登记范围
281 个肿瘤登记处
分期数据可用性
未发布

以中文写出的数值按来源原样引用。

查看全部生存率 →

如何解读该数据。 它按全分期合并发布,因此是全国登记数据中所有人的平均值,而不是对某个人的预后。对多数癌症而言,确诊时的分期是生存差异背后最强的单一因素:通常,癌症发现得越早,生存率越高;发现得越晚,越低。不同癌症之间的比较也受到各自通常确诊早晚的影响,因此一个较低的数值本身并不意味着诊疗更差。

该数值是相对生存率:它把被诊断患此癌的人与一般人群中同年龄、同性别的人相比较,且为年龄标准化,因此它不是五年后仍存活患者所占的比例。它以估计值(混合分析)发布,因为登记报告存在滞后,故国家癌症中心对最近一段时期作了模型估计。作为参照,同一来源发布 2019–2021 年全部癌症合计的五年相对生存率为 43.7%。

在该疾病上有已发布记录的医院

依据官方公开数据来源筛选

这些医院依据官方公开数据来源筛选——复旦大学医院专科声誉排行榜、国家临床重点专科名单与国家临床医学研究中心——因此卡片上的每一行都可与其已发布的来源核对。这不是付费或推广位。

这些医院是如何筛选的

入选。当某疾病所归属的专科满足以下至少一项时,医院即被列入该疾病:在复旦大学医院专科声誉排行榜中有一个名次或提名;有一条 A、B 或 C 级的国家临床重点专科记录;或该专科有一个国家临床医学研究中心或国家重点实验室。JCI 认证仅作徽标展示;它绝不决定入选,也绝不决定排序。

排序。第 1 步:该专科在复旦榜中的第 1 至第 10 名。第 2 步:又一个复旦名次,或一个提名。第 3 步:一条 A 级国家临床重点专科。第 4 步:一条 B 级国家临床重点专科。第 5 步:该专科的一个国家临床医学研究中心或国家重点实验室,研究中心优先于实验室。第 6 步:一条 C 级国家临床重点专科——这是我们发布的一条没有独立官方来源的记录,因此排在其余之后。

平局。在同一步骤内:复旦名次更好的在前,其次重点专科等级更高者(A 先于 B,B 先于 C),再次省份,再次城市,最后医院名称——与医院目录所用的省—市—名称顺序相同。最多列出八家医院。

当名单较短时。五家及以上:列出前八家。三家或四家:全部列出,并有一个可展开的折叠区,把其余记录补至最多八条,每条都带其证据等级。一两家:同上,且该折叠区默认展开,并有一行说明有多少家医院有可靠的公开记录。没有:页面说明未找到可靠的公开记录,并链接到专科目录。绝不为了凑数而编造名次、机构或数量。

复旦排行榜是中国临床医生最广泛认可的医院专科声誉排行榜,由复旦大学医院管理研究所每年发布。

  1. 四川大学华西医院West China Hospital, Sichuan University

    Chengdu 成都市

    国家临床重点专科

    同时上榜:在复旦榜中为 General Surgery #3, Thoracic Surgery #4, Urology #2 (并列)。

  2. 中国医学科学院肿瘤医院Cancer Hospital of Chinese Academy of Medical Sciences

    Beijing 北京市

    国家临床重点专科

    已发表研究

    PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

    同时上榜:在复旦榜中为 Thoracic Surgery #1, Medical Oncology #1, Urology 获提名。

  3. 中日友好医院China-Japan Friendship Hospital

    Beijing 北京市

    国家临床重点专科

    已发表研究

    另有 1 项已发表研究

    PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

    同时上榜:在复旦榜中为 Respiratory Medicine #2, Thoracic Surgery 获提名。

  4. 华中科技大学同济医学院附属同济医院Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology

    Wuhan 武汉市

    国家临床重点专科

    同时上榜:在复旦榜中为 General Surgery #6, Urology #5, Gynecology #2。

  5. 陕西省人民医院Shaanxi Provincial People's Hospital

    Xi'an 西安市

    国家临床重点专科

    已发表研究

    PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

临床试验(在研治疗)

除标准治疗外,针对 Stomach cancer 的临床研究目前可能在中国开放招募受试者。在研治疗尚未获监管机构批准为标准疗法——它们是临床研究,而非常规治疗。每条记录都注明主要研究者与开展研究的医院。如有兴趣,请联系医院了解是否符合条件,并自行决定是否申请。

  1. 研究 Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer

    主要研究者
    Hui Ye · Professor
    医院
    Hunan Cancer Hospital
    状态
    招募中
    登记库
    NCT06543108
  2. 研究 The Effect of Perioperative Rehabilitation Programme Delivered Via a Smart Phone Based Digital Platform in Patients Undergoing Neoadjuvant Therapy for Gastric Cancer Surgery: Study Protocol for a Randomised Controlled Trial

    主要研究者
    JunZhang · Chief Surgeon
    医院
    Beijing Friendship Hospital, Capital Medical University
    状态
    招募中
    登记库
    NCT07441850
  3. 研究 Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer: A Multicenter Randomized Controlled Trial Study

    医院
    Beijing Friendship Hospital, Capital Medical University
    状态
    招募中
    登记库
    NCT06788548
  4. 研究 The Study of Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Initial Unresectable Local Advanced or Potentially Resectable Metastatic Gastric Adenocarcinoma

    主要研究者
    Zhaode Bu · Clinical Professor
    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT04047953
  5. 研究 Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer: A Community-Based Randomized Controlled Trial

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT06306755
另有 60 项已登记研究
  1. 研究 Prospective Cohort Study on the Efficacy, Adverse Effects, and Biomarkers of First-Line/Neoadjuvant Therapy With Immune Checkpoint Inhibitors Combined With Chemotherapy in Advanced Gastric Cancer

    主要研究者
    Lian Liu, MD, PHD · Professor, Chief Physician
    医院
    Qilu Hospital of Shandong University
    状态
    招募中
    登记库
    NCT06727981
  2. 研究 A Study on the Safety and Efficacy of Leucine-Restricted Diet in Gastric Cancer Patients Treated With Neoadjuvant Chemotherapy and Immunotherapy

    医院
    Qilu Hospital of Shandong University
    状态
    招募中
    登记库
    NCT07537361
  3. 研究 Exploratory Study of NK510 Cell Therapy in the Treatment of Recurrent and Refractory Advanced Gastric Cancer and Colorectal Cancer

    医院
    Nanjing Drum Tower Hospital
    状态
    招募中
    登记库
    NCT07166263
  4. 研究 Phase Ⅱ Study of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis

    医院
    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    状态
    招募中
    登记库
    NCT06685887
  5. 研究 Diagnostic and Predictive Performance of Dual-/ Muti- Energy CT and MRI in the Treatment Response and Survival Prognosis of Gastric Cancer

    主要研究者
    Zihao Zhao · The First Affiliated Hospital of Zhengzhou University
    医院
    First Affiliated Hospital of Zhengzhou University
    状态
    招募中
    登记库
    NCT06869694
  6. 研究 Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Adenocarcinoma of the Gastric and Oesophagogastric Junction: an Open-label, Prospective, Multicenter, Randomised, Phase 2 Trial.

    医院
    The Sixth Affiliated Hospital, Sun Yat-sen University
    状态
    招募中
    登记库
    NCT06510010
  7. 研究 Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer

    状态
    招募中
    登记库
    NCT06979895
  8. 研究 The Application and Effect of Goal-oriented Albumin Infusion in the Control of Postoperative Complications in Patients With Gastric Cancer - a Single-center Prospective Non- Randomized Controlled Study

    主要研究者
    Yuchen Guo, Ph.D. · Prof.
    医院
    The First Hospital of Jilin University
    状态
    招募中
    登记库
    NCT07119463
  9. 研究 Establishing an Innovative Cohort for Chinese Early Gastric Cancer Patients Based on the National Clinical Research Center for Digestive Diseases Prospective Database: A Retrospective Study

    主要研究者
    JunZhang · Chief Surgeon
    医院
    Beijing Friendship Hospital, Capital Medical University
    状态
    招募中
    登记库
    NCT07747688
  10. 研究 A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer with SOX Plus Tislelizumab Combined with HIPEC

    主要研究者
    Yan Shi
    状态
    招募中
    登记库
    NCT06760858
  11. 研究 A Multicenter, Prospective, Randomized Controlled Clinical Study of Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer

    主要研究者
    Yan Shi
    状态
    招募中
    登记库
    NCT06791538
  12. 研究 Comparison of Gastroesophageal Reflux and Quality of Life Between Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer Patients

    医院
    Qilu Hospital of Shandong University
    状态
    招募中
    登记库
    NCT07635836
  13. 研究 A Study on the Safety and Efficacy of Leucine-Restricted Diet in Gastric Cancer Patients Treated With Chemotherapy and Immunotherapy

    医院
    Qilu Hospital of Shandong University
    状态
    招募中
    登记库
    NCT07537348
  14. 研究 A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer

    医院
    Jiangsu Province Hospital
    状态
    招募中
    登记库
    NCT06555471
  15. 研究 The Clinical Significance of Examining Metastatic Lymph Nodes in Respective Gastric Mesenteries in the Gastric Cancer Patients Who Received D2 Lymphadenectomy Plus Complete Mesogastric Excision

    主要研究者
    Jichao Qin · professor
    医院
    The First Affiliated Hospital, Zhejiang University School of Medicine
    状态
    招募中
    登记库
    NCT07139418
  16. 研究 A Prospective Cohort Study on Serum Immune Protein Signature for Predicting Neoadjuvant Therapy Efficacy in Advanced Gastric Cancer

    医院
    Zhongshan Hospital
    状态
    招募中
    登记库
    NCT06662110
  17. 研究 A Randomized,Multicenter, Open-Label,Phase II/III Study to Evaluate the Safety and Efficacy of Disitamab Vedotin Combined With Cadonilimab in Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Adenocarcinoma Who Have Progressed on r First-line Therapy

    医院
    Peking University Cancer Hospital
    状态
    招募中
    登记库
    NCT06221748
  18. 研究 Single Center, Phase II Clinical Study of PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer

    医院
    Peking University Third Hospital
    状态
    招募中
    登记库
    NCT06792162
  19. 研究 A Prospective, Single-Arm, Phase Ⅱ Clinical Trial Evaluating Fruquintinib in Combination With Paclitaxel for Injection (Albumin-bound) and Iparomlimab and Tuvonralimab Injection as Second-Line Therapy in Advanced Gastric Cancer Patients Previously Received Immunotherapy

    主要研究者
    Dai, Guanghai · Professor,Chief Physician
    医院
    Chinese PLA General Hospital
    状态
    招募中
    登记库
    NCT07392346
  20. 研究 Fecal Microbiota Transplantation Combined with SOX and Sintilimab As First-line Treatment for Advanced Gastric Cancer:A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study (FMT-JSNO-01)

    主要研究者
    Hua Jiang · MD
    医院
    Changzhou No.2 People's Hospital
    状态
    招募中
    登记库
    NCT06405113
  21. 研究 Perioperative S-1 Plus Oxaliplatin Combined With Serplulimab or Placebo for Locally Advanced Gastric Adenocarcinoma With Proficient Mismatch Repair: a Prospective, Multi-center, Double-blinded, Randomized Placebo-controlled Study

    主要研究者
    Yu jiren · Professor
    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT05872685
  22. 研究 A Prospective, Multicentre, Double-blind Randomized Controlled Clinical Study of the Efficacy and Safety of Taurine Combined With Serplulimab and Chemotherapy Versus Serplulimab Combined With Chemotherapy for Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

    医院
    Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
    状态
    招募中
    登记库
    NCT06128252
  23. 研究 A Radio-Pathomic Multimodal Machine Learning Model for Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Advanced Gastric Cancer: A Retrospective Observational Study

    医院
    The Sixth Affiliated Hospital, Sun Yat-sen University
    状态
    招募中
    登记库
    NCT06451393
  24. 研究 A Single-arm, Open-label, Multicenter Phase 2 Study to Evaluate XELOX + Tislelizumab in Combination With Doxorubicin Hydrochloride Liposome Injection (XELOX+PD-1+PLD)as Neoadjuvant Therapy for Resectable Gastric Cancer

    主要研究者
    Qi Li · Chief Physician
    医院
    Shanghai General Hospital
    状态
    招募中
    登记库
    NCT05536102
  25. 研究 A Multicenter, Prospective, Observational Cohort Study to Assess the Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer (STARS-GC09)

    主要研究者
    Quan Wang · Director, Clinical Professor
    医院
    The First Hospital of Jilin University
    状态
    招募中
    登记库
    NCT06881043
  26. 研究 Clinical Study on the Efficacy and Safety of Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression

    医院
    Tianjin Medical University Cancer Institute & Hospital
    状态
    招募中
    登记库
    NCT06560528
  27. 研究 Samples Procurement for Patients With Colorectal Cancer, Gastric Cancer, and Non-malignant Disease Undergoing Surgery

    主要研究者
    Tao Fu · Director of Department of GI Surgery II
    医院
    Renmin Hospital of Wuhan University
    状态
    招募中
    登记库
    NCT03972956
  28. 研究 A Prospective, Multicenter, Randomized, Controlled Study of the Clinical Efficacy of Robotic and Laparoscopic Radical Gastrectomy in Neoadjuvant Gastric Cancer Patients

    医院
    The Affiliated Hospital of Qingdao University
    状态
    招募中
    登记库
    NCT06042998
  29. 研究 Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer: a Single-arm, Open Clinical Study

    医院
    The First Affiliated Hospital of Fujian Medical University
    状态
    招募中
    登记库
    NCT06791083
  30. 研究 Development and Validation of an Explainable Artificial Intelligence Model for Early Gastric Cancer Diagnosis Using Multimodal Endoscopic Imaging

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT07551466
  31. 研究 A Phase II, Open-Label, Multicenter Trial Comparing Disitamab Vedotin Plus Sintilimab and S-1 With Trastuzumab Plus Chemotherapy ± Sintilimab for First-Line Treatment of HER2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (RCTS2)

    主要研究者
    Lian Liu, MD, PHD · Director
    医院
    First Affiliated Hospital of Zhengzhou University
    状态
    招募中
    登记库
    NCT06730373
  32. 研究 Efficacy and Safety of Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids in Gastric Cancer Malignant Ascites: a Phase I/II Clinical Study (IPIZA)

    主要研究者
    Lian Liu, MD, PHD · Professor
    医院
    Qilu Hospital of Shandong University
    状态
    招募中
    登记库
    NCT06759064
  33. 研究 A Prospective, Randomised Placebo Controlled Trial of Faecal Microbiota Transplantation in Patients With Advanced Gastric Cancer

    主要研究者
    Xiangyu Kong
    状态
    招募中
    登记库
    NCT06346093
  34. 研究 A Randomized, Controlled, Open-Label, Multicenter Clinical Trial Comparing Anti-HER2 Therapy Combined With Chemotherapy to Chemotherapy Alone as Adjuvant Therapy Following Surgery for Stage IB-II Gastric Cancer With High HER2 Expression

    医院
    First Affiliated Hospital of Guangzhou Medical University
    状态
    招募中
    登记库
    NCT07788196
  35. 研究 Prospective, Phase II Clinical Study of Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer

    医院
    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    状态
    招募中
    登记库
    NCT06487429
  36. 研究 Clinical Study of SHR1701 in Combination With CAPOX and SHR2554 or Apatinib for First-line Treatment of Advanced Gastric Cancer

    主要研究者
    Yongxu Jia · Chief Investigator
    医院
    First Affiliated Hospital of Zhengzhou University
    状态
    招募中
    登记库
    NCT07294664
  37. 研究 Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy With D2 Lymphadenectomy Plus Complete Mesogastric Excision for Gastric Cancer: A Prospective Observational Study

    主要研究者
    Jichao Qin · Professor
    医院
    The First Affiliated Hospital, Zhejiang University School of Medicine
    状态
    招募中
    登记库
    NCT06728878
  38. 研究 Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer : a Phase Il Study

    主要研究者
    Zhongguang Luo, MD · Chief Physician
    医院
    Huashan Hospital
    状态
    招募中
    登记库
    NCT06054906
  39. 研究 A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer

    主要研究者
    YiHui Guan · Professor
    医院
    Huashan Hospital
    状态
    招募中
    登记库
    NCT07707531
  40. 研究 Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study

    医院
    Zhongshan Hospital
    状态
    招募中
    登记库
    NCT05347524
  41. 研究 Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric:MetBio-GC

    医院
    Ruijin Hospital
    状态
    招募中
    登记库
    NCT07076979
  42. 研究 A Phase 1/1b Study of ASP2138 as Monotherapy and in Combination With Pembrolizumab and mFOLFOX6 or Ramucirumab and Paclitaxel in Participants With Metastatic or Locally Advanced Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma and in Combination With mFOLFIRINOX in Participants With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Whose Tumors Have Claudin (CLDN) 18.2 Expression

    医院
    Sun Yat-sen University Cancer Center
    状态
    招募中
    登记库
    NCT05365581
  43. 研究 The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial

    主要研究者
    Lin Chen · Prof.
    医院
    Chinese PLA General Hospital
    状态
    招募中
    登记库
    NCT07212933
  44. 研究 Effect of Family-Supervised Multimodal Prehabilitation Throughout Preoperative Neoadjuvant Chemotherapy on Clinical Outcomes in Gastric Cancer Patients: A Single-Center Randomized Controlled Trial

    主要研究者
    Zhou Yanbing · Chief Physician, Affiliated Hospital of Qingdao University
    医院
    The Affiliated Hospital of Qingdao University
    状态
    尚未招募
    登记库
    NCT07183358
  45. 研究 Efficacy and Safety of Beta-Blockers Combined With Neoadjuvant Immunotherapy for Locally Advanced Gastric Cancer: an Open-lable, Single-arm Study

    医院
    Nanfang Hospital
    状态
    尚未招募
    登记库
    NCT07511894
  46. 研究 Multicenter Randomized Controlled Clinical Study on Acupuncture Combined With Adjuvant Chemotherapy for the Prevention of Recurrence and Metastasis After Gastric Cancer Surgery

    医院
    The First Affiliated Hospital, Sun Yat-sen University
    状态
    尚未招募
    登记库
    NCT07098949
  47. 研究 A Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric Cancer

    主要研究者
    Zhongguang Luo, MD · Chief Physician
    医院
    Huashan Hospital
    状态
    尚未招募
    登记库
    NCT06957977
  48. 研究 A Prospective Exploratory Study of a HIPEC Priming Strategy Followed by Serplulimab Combined With SOX/XELOX as Neoadjuvant Therapy for Locally Advanced Gastric Cancer

    主要研究者
    weijun wang
    状态
    尚未招募
    登记库
    NCT07621484
  49. 研究 Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Open-Label, Randomized, Multi-Centered Phase III Trial

    主要研究者
    Yihong Sun · Chief of Gastrointestinal Surgery Department
    医院
    Zhongshan Hospital
    状态
    尚未招募
    登记库
    NCT07508956
  50. 研究 A Single-arm, Open-label Phase I/II Study to Evaluate the Safety and Preliminary Efficacy of Hypoxia-Inducible CD73/AXL-Targeting CAR-T Cells (XW-LTH-03) in Patients With Advanced Gastric Cancer

    医院
    Zhongshan Hospital
    状态
    尚未招募
    登记库
    NCT07333573
  51. 研究 A Multicenter, Prospective, Real-world Study Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer

    主要研究者
    Zheng Zhichao · Offices Director
    医院
    Liaoning Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07132528
  52. 研究 A Multicenter, Prospective, Real-world Study Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical Surgery

    主要研究者
    Zheng Guoliang · Vice Offices Director
    医院
    Liaoning Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07149181
  53. 研究 A Single-centre Phase II Clinical Study of Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction Adenocarcinoma

    主要研究者
    Zheng Zhichao · Offices Director
    医院
    Liaoning Cancer Hospital
    状态
    尚未招募
    登记库
    NCT06764251
  54. 研究 A Prospective, Multicenter, Randomized, Controlled Study of the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer

    主要研究者
    Chang-Ming Huang, Prof. · Professor
    医院
    Fujian Medical University Union Hospital
    状态
    尚未招募
    登记库
    NCT05235932
  55. 研究 A Prospective, Multicenter, Phase III Randomized Controlled Trial Evaluating the Impact of Radical Surgery Versus Non-Surgery on Prognosis and Quality of Life in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy (ALANO Study, CGCA2603 Study)

    主要研究者
    Hua Huang, MD, PhD · Professor, Department of Gastric Surgery, Fudan University Shanghai Cancer Center
    医院
    Peking University Cancer Hospital
    状态
    尚未招募
    登记库
    NCT07789184
  56. 研究 Effect of Prophylactic Hyperthermic Intraperitonal Chemotherapy(HIPEC)After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer(cT3N+M0 and cT4aN+/-M0): A Randomized-controlled Study

    医院
    The First Hospital of Jilin University
    状态
    尚未招募
    登记库
    NCT06525714
  57. 研究 TACE Combined With Thermal Ablation and Antibody-drug Conjugates, Immune Checkpoint Inhibitors, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: a Multicenter, Single-arm Prospective Clinical Study.

    医院
    Shandong Provincial Hospital
    状态
    尚未招募
    登记库
    NCT07602140
  58. 研究 Clinical Efficacy and Safety Evaluation of Submucosal Injection of Indocyanine Green Tracer in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer: a Prospective, a Multicenter, Randomized, Controlled Study Clinical Trial

    主要研究者
    Wenbin Yu · Professor, and Chief of Gastrointestinal Surgery Department
    医院
    Qilu Hospital of Shandong University
    状态
    尚未招募
    登记库
    NCT06421220
  59. 研究 A Prospective, Single-center, Phase II Clinical Study of First-line Treatment for HER2 (Human Epidermal Growth Factor Receptor 2) Overexpressing Advanced Gastric Cancer With Disitamab Vedotin in Combination With Cadonilimab

    主要研究者
    Yongxu Jia · Chief Physician
    医院
    First Affiliated Hospital of Zhengzhou University
    状态
    尚未招募
    登记库
    NCT06492317
  60. 研究 Liposomal Irinotecan in Combination with Sintilimab in Second-Line Treatment of Progressive Gastric Cancer, a Single-Arm, Single-Center, Open-Label, Phase II Clinical Study

    主要研究者
    Hao Li · Principal Investigator
    医院
    Ruijin Hospital
    状态
    尚未招募
    登记库
    NCT06697366

本页仅分享公开登记的研究信息,不推荐也不鼓励参加任何研究。参加完全自愿,且未经批准治疗的风险尚不明确;请直接联系医院了解入组条件与知情同意细节。

拥有国家临床重点专科记录的医院

显示医院记录 5 家拥有重点专科记录的医院

每一行都是在某疾病所归属专科中拥有国家临床重点专科记录的医院。这是对已发布名单的记录,既不构成推荐,也不是排名。

5 家拥有匹配的国家临床重点专科记录的医院。

以中文写出的数值按来源原样引用。

患者报告的情况

仅为汇总数据:一项全国性结果,附其来源与所指年份。这不是患者证言,也不是关于某一个人的陈述。

  • 据 National Health Commission - 2023 national tertiary public hospital performance monitoring circular (国卫医政函〔2025〕55 号)(2023)报道:National inpatient satisfaction / outpatient satisfaction — 95.42 / 93.95 score, 0-100。

    National aggregate across the 2,168 tertiary public hospitals that took part in the national performance monitoring (all conditions combined; not disease-specific, not hospital-specific).

    来源:National Health Commission - 2023 national tertiary public hospital performance monitoring circular (国卫医政函〔2025〕55 号) — https://www.gov.cn/zhengce/zhengceku/202503/content_7016208.htm — 2023 — A 级

全部疗法与获取主题

关于该疾病的问题

我们不能提供医疗建议,但可以回答关于本页以及在中国安排就医的问题。

咨询这个病种

ICD 编码

显示编码表 10 个 ICD 编码
版本 编码 该版本中的名称
ICD-10-WHO C16 Malignant neoplasm of stomach
ICD-10-WHO C16.0 Cardia
ICD-10-WHO C16.1 Fundus of stomach
ICD-10-WHO C16.2 Body of stomach
ICD-10-WHO C16.3 Pyloric antrum
ICD-10-WHO C16.4 Pylorus
ICD-10-WHO C16.5 Lesser curvature of stomach, unspecified
ICD-10-WHO C16.6 Greater curvature of stomach, unspecified
ICD-10-WHO C16.8 Overlapping lesion of stomach
ICD-10-WHO C16.9 Stomach, unspecified

各行为该疾病的 WHO ICD-10 条目,按原样引用。

来源与证据

来源 URL
https://wjw.fujian.gov.cn/xxgk/fgwj/zxwj/201904/P020190412506737868905.xlsx
来源协议
https
来源类型
省级卫生健康委员会
证据等级
A ——由卫生健康委员会、国家级研究机构或大学所述
获取日期
2026-09-24